No profile data available.
Structure Therapeutics Inc. (GPCR) is a healthcare company in the obesity treatment pharmaceuticals industry, based in South San Francisco, United States, with about 281 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$141.20 million. Its market capitalization was $1.82 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
Structure Therapeutics reported $0 in revenue for fiscal year 2025.
$1.82 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (obesity treatment pharmaceuticals) include Metsera, Inc. (MTSR), Rhythm Pharmaceuticals, Inc. (RYTM), BioAge Labs, Inc. (BIOA), Aardvark Therapeutics, Inc. (AARD).